OmniActive Health Technologies has announced the acquisition of ENovate Biolife (ENovate), a developer of proprietary, clinically researched botanical ingredients for health solutions for an unspecified amount.
“This deal, funded through internal accruals, has further strengthened the Company’s commitment to providing high-quality, scientifically validated health ingredients to consumers globally,” the company said in a statement.
This transaction marks OmniActive’s second strategic expansion, following its purchase of Bangalore-based botanical ingredients company IndFrag in 2017.
“ENovate’s approach to ingredients perfectly aligns with OmniActive’s mission of delivering proven products that make a meaningful difference in consumers’ lives,” said Sanjaya Mariwala, Executive Chairman and Managing Director, OmniActive.
“ENovate has done a remarkable job bringing multiple standout ingredients to the market including Muvz, RedNite, and the award-winning Oxyjun. This acquisition is in line with our long-term growth strategy of diversifying product portfolios, accessing new customers and technologies and expanding our presence to new geographies,” he added.
Published - November 06, 2024 11:50 pm IST
Disclaimer: The copyright of this article belongs to the original author. Reposting this article is solely for the purpose of information dissemination and does not constitute any investment advice. If there is any infringement, please contact us immediately. We will make corrections or deletions as necessary. Thank you.
